Dušica Gavrilović

Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study

S. Jelić, Labuda Mitrović, Davorin Radosavljević et al. · Lung Cancer · 2001 · 43 citations

Medicine, Oncology, Pharmacology +13

Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy

M. Jevric, Ivana Z. Matić, Ana Krivokuća et al. · BMC Cancer · 2019 · 30 citations · Full text

Medicine, Oncology, Breast Oncology +14

Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors

Aleksandra Erić-Nikolić, Ivana Z. Matić, Zorka Milovanović et al. · Immunobiology · 2011 · 28 citations

Medicine, Immunology, Oncology +12

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients

Neda Nikolić, Davorin Radosavljević, Dušica Gavrilović et al. · Medicina · 2021 · 28 citations · Full text

Medicine, Oncology, Surgery +17

pSTAT3 expression associated with survival and mammographic density of breast cancer patients

Sandra Radenković, Gordana Konjević, Dušica Gavrilović et al. · Pathology - Research and Practice · 2018 · 26 citations · Full text

Medicine, Cancer Biology, Oncology +13